Your browser doesn't support javascript.
loading
Effects of interferon regulatory factor 9 on the biological phenotypes in PML-RARα-induced promyelocytic leukemia / 中华血液学杂志
Chinese Journal of Hematology ; (12): 370-375, 2022.
Article em Zh | WPRIM | ID: wpr-929570
Biblioteca responsável: WPRO
ABSTRACT
Objective: To investigate the prognostic significance of interferon regulatory factor 9 (IRF9) expression and identify its role as a potential therapeutic target in acute promyelocytic leukemia (APL) . Methods: The gene expression profile and survival data applied in the bioinformatic analysis were obtained from The Cancer Genome Atlas and Beat acute myeloid leukemia (AML) cohorts. A dox-induced lentiviral system was used to induce the expression of PML-RARα (PR) in U937 cells, and the expression level of IRF9 in U937 cells treated with or without ATRA was examined. We then induced the expression of IRF9 in NB4, a promyelocytic leukemia cell line. In vitro studies focused on leukemic phenotypes triggered by IRF9 expression. Results: ①Bioinformatic analysis of the public database demonstrated the lowest expression of IRF9 in APL among all subtypes of AML, with lower expression associated with worse prognosis. ②We successfully established a PR-expression-inducible U937 cell line and found that IRF9 was downregulated by the PR fusion gene in APL, with undetectable expression in NB4 promyelocytic cells. ③An IRF9-inducible NB4 cell line was successfully established. The inducible expression of IRF9 promoted the differentiation of NB4 cells and had a synergistic effect with lower doses of ATRA. In addition, the inducible expression of IRF9 significantly reduced the colony formation capacity of NB4 cells. Conclusion: In this study, we found that the inducible expression of PR downregulates IRF9 and can be reversed by ATRA, suggesting a specific regulatory relationship between IRF9 and the PR fusion gene. The induction of IRF9 expression in NB4 cells can promote cell differentiation as well as reduce the colony forming ability of leukemia cells, implying an anti-leukemia effect for IRF9, which lays a biological foundation for IRF9 as a potential target for the treatment of APL.
Assuntos
Palavras-chave
Texto completo: 1 Índice: WPRIM Assunto principal: Fenótipo / Tretinoína / Leucemia Mieloide Aguda / Leucemia Promielocítica Aguda / Proteínas de Fusão Oncogênica / Diferenciação Celular / Células U937 / Fator Gênico 3 Estimulado por Interferon, Subunidade gama Tipo de estudo: Prognostic_studies Limite: Humans Idioma: Zh Revista: Chinese Journal of Hematology Ano de publicação: 2022 Tipo de documento: Article
Texto completo: 1 Índice: WPRIM Assunto principal: Fenótipo / Tretinoína / Leucemia Mieloide Aguda / Leucemia Promielocítica Aguda / Proteínas de Fusão Oncogênica / Diferenciação Celular / Células U937 / Fator Gênico 3 Estimulado por Interferon, Subunidade gama Tipo de estudo: Prognostic_studies Limite: Humans Idioma: Zh Revista: Chinese Journal of Hematology Ano de publicação: 2022 Tipo de documento: Article